Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Papillary Carcinoma”

368 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 368 results

Testing effectiveness (Phase 2)Study completedNCT00025467
What this trial is testing

Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer

Who this might be right for
Endometrial AdenoacanthomaEndometrial AdenocarcinomaEndometrial Adenosquamous Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT01103557
What this trial is testing

Prophylactic Selective Lateral Neck Dissection in Patients With Papillary Thyroid Carcinoma

Who this might be right for
Thyroid NeoplasmLymphatic Metastasis
Pusan National University Hospital 62
Not applicableNot Yet RecruitingNCT06901908
What this trial is testing

Role of Cytomorphometry and BRAFV600E Immunocytochemistry With a Cytologic Diagnosis "Suspicious for Papillary Thyroid Carcinoma"

Who this might be right for
Suspicious for Papillary Thyroid Carcinoma
Assiut University 45
Testing effectiveness (Phase 2)Study completedNCT03037385
What this trial is testing

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

Who this might be right for
RET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more
Hoffmann-La Roche 590
Not applicableUnknownNCT03411187
What this trial is testing

Study on the Application of Convenient Foot-control Exhaust Method in Endoscopic Thyroidectomy

Who this might be right for
Thyroid CancerPapillary Thyroid CarcinomaThyroidectomy+1 more
Bo Wang,MD 100
Large-scale testing (Phase 3)Study completedNCT00295763
What this trial is testing

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Who this might be right for
Differentiated Thyroid Cancer
Genzyme, a Sanofi Company 61
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableNot Yet RecruitingNCT06725628
What this trial is testing

Multiomics Study of Biological Behavior of Lymph Node Metastasis in Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaLymph Node Cancer Metastatic
Tianhan Zhou 2,000
Not applicableUnknownNCT04312087
What this trial is testing

Lateral Neck Lymph Node Mapping in Thyroid Cancer

Who this might be right for
Thyroid Cancer
Fudan University 250
Testing effectiveness (Phase 2)Study completedNCT01108445
What this trial is testing

Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

Who this might be right for
Advanced Non-clear Cell Renal Cell Carcinoma
Duke University 131
Not applicableLooking for participantsNCT05766098
What this trial is testing

Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY

Who this might be right for
Papillary Thyroid Cancer
Istituto Auxologico Italiano 600
Early research (Phase 1)Study completedNCT05410821
What this trial is testing

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Who this might be right for
Refractory Thyroid Gland CarcinomaRefractory Thyroid Gland Papillary CarcinomaRefractory Thyroid Gland Follicular Carcinoma+1 more
The First Affiliated Hospital of Xiamen University 12
Testing effectiveness (Phase 2)UnknownNCT01118065
What this trial is testing

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Leiden University Medical Center 42
Not applicableLooking for participantsNCT07140757
What this trial is testing

Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers

Who this might be right for
Low RiskPapillary Thyroid CancerRadiofrequency Ablation
M.D. Anderson Cancer Center 50
Not applicableActive Not RecruitingNCT04948437
What this trial is testing

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

Who this might be right for
Thyroid CancerPapillary Thyroid CancerFollicular Thyroid Cancer
National Taiwan University Hospital 103
Testing effectiveness (Phase 2)Ended earlyNCT00653328
What this trial is testing

Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Who this might be right for
Fallopian Tube CancerOvarian CancerPeritoneal Cavity Cancer
Vanderbilt-Ingram Cancer Center 15
Not applicableStudy completedNCT05132205
What this trial is testing

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

Who this might be right for
Papillary Thyroid Cancer
Johns Hopkins University 10
Not applicableLooking for participantsNCT07357571
What this trial is testing

Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound

Who this might be right for
Thyroid Papillary CarcinomaContrast Enhanced Ultrasound
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 600
Early research (Phase 1)Ended earlyNCT03469011
What this trial is testing

Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Who this might be right for
Papillary Thyroid Cancer
AHS Cancer Control Alberta 14
Early research (Phase 1)Study completedNCT01413113
What this trial is testing

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
University of Washington 6
Load More Results